InMed Pharmaceuticals's total assets for Q2 2026 were C$15.36M, a decrease of -17.57% from the previous quarter. INM total liabilities were C$2.20M for the fiscal quarter, a -10.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.